You are here:
Funding
Types of Research and Training Programs
Updated October 7, 2009
This list is an NIAMS-specific excerpt from the NIH list of activity codes.
Fellowship Programs ( F )
Research Career Awards ( K )
Research Programs and Centers ( P )
Research Project Grants ( R )
American Recovery and Reinvestment Act (RC)
Training Programs ( T )
Cooperative Agreements ( U )
Supplement Programs
Note: For supplements to funded research grants to support training and career development of under-represented minorities, people from socioeconomically disadvantaged backgrounds or persons with disabilities please see Supplement Programs
|
Top |
|
|
Predoctoral Fellowship to Promote Diversity in Health-Related Research
Predoctoral Fellowship Awards for Students with Disabilities |
| Predoctoral for support of research leading to the Ph.D. or equivalent research degree for individuals to extend their potential for a career in research in arthritis, muscle, bone, musculoskeletal, and/or skin diseases. U.S. citizenship or permanent resident status is required. |
| Duration: Up to 5 years |
| Commitment: Full-time research fellowship |
| Provisions: See FY2009 NIH Guide Notice |
| Institutional Allowance: See FY2009 NIH Guide Notice |
| Applications Due: April 13, August 13, December 13 |
|
See active F31 funding opportunities
|
|
|
|
| Postdoctoral Individual National Research Service Award |
| To provide postdoctoral research training to individuals to broaden their scientific background and extend their potential for research in arthritis, muscle, bone, musculoskeletal, and/or skin diseases. Requires M.D. or Ph.D. or equivalent |
| Duration: Up to 3 years |
| Commitment: Full-time research fellowship |
| Provisions: See FY2009 NIH Guide Notice |
| Institutional Allowance: See FY2009 NIH Guide Notice |
| Applications Due: Standard dates |
|
See active F32 funding opportunities
|
|
|
|
| Senior Fellowship |
| Fellowships to provide opportunities for experienced scientists to make major changes in the direction of research careers, to broaden scientific background, and to acquire new research capabilities regarding arthritis, muscle, bone, musculoskeletal, and/or skin diseases. U.S. citizenship or permanent resident status is required. Level: At least 7 years postdoctoral (this is a "sabbatical" award) |
| Duration: Up to 2 years |
| Commitment: Full-time research fellowship |
| Provisions: See FY2009 NIH Guide Notice (no fringe benefits) |
| Institutional Allowance: See FY2009 NIH Guide Notice |
| Applications Due: Standard dates |
|
See active F33 funding opportunities
|
|
Note: For supplements to funded research grants to support training and career development of under-represented minorities, people from socioeconomically disadvantaged backgrounds or persons with disabilities please see Supplement Programs
|
Top |
|
|
| Mentored Research Scientist Development Awards |
| To provide research scientists with an additional period of sponsored research experience as a way to gain expertise in a research area new to the applicant or in an area that would demonstrably enhance the applicant's scientific career. These awards are generally reserved for individuals interested in switching to a new research field, for individuals who have interrupted their career because of illness or pressing family care responsibilities, or for faculty at minority institutions who wish to enhance their capacity for independent research. |
| Duration: Up to 5 years |
| Provisions: Support is provided for salary up to $75,000 for a minimum 75% effort, fringe benefits, and other research expenses up to $20,000. |
| Applications Due: Standard dates |
|
See active K01 funding opportunities
|
|
|
|
| Independent Research Scientist Development Awards |
| NIAMS no longer participates in this grant mechanism. |
|
|
|
| Mentored Clinical Scientist Development Investigator Awards |
| To support clinicians who need an intensive period of mentored research experience. |
| Duration: Up to 5 years |
| Provisions: *Support is provided for salary up to $75,000 for a minimum 75% effort, fringe benefits, and other research expenses up to $20,000. |
| Applications Due: Standard dates |
| *Please see NOT-AR-07-001 |
|
See active K08 funding opportunities
|
|
|
|
| Mentored Patient-Oriented Research Career Development Award |
| To support supervised study and research for clinically trained professionals who have the potential to develop into productive, clinical investigators focusing on patient-oriented research. Candidates must have completed their specialty and, if applicable, subspecialty training prior to receiving an award. |
| Duration: 3 to 5 years |
| Provisions: *Support is provided for salary up to $75,000 for a minimum 75% effort, fringe benefits, and other research expenses up to $25,000. |
| Applications Due: Standard dates |
| *Please see NOT-AR-07-001 |
|
See active K23 funding opportunities
|
|
|
|
| Midcareer Investigator Award in Patient-Oriented Research
|
| To support protected time for clinicians to allow them time for patient-oriented research and to act as mentors for beginning clinical investigators. Candidates must have completed their specialty training within 15 years of submitting the application. Candidates must be working in a research environment, conducting patient-oriented research, and have independent research support. |
| Duration: 3 to 5 years. |
| Provisions: Support up to 50% of the NIH salary cap ($196,700 in FY 2009) is provided and up to $50,000 in selected research expenses. |
| Applications Due: Standard dates |
|
See active K24 funding opportunities
|
|
|
|
| Mentored Quantitative Research Career Development Award |
| To support supervised study and research for investigators with quantitative scientific and engineering backgrounds outside of biology or medicine who have made a commitment to focus their research endeavors on biomedical research. This mechanism is aimed at research-oriented scientists with experience at the level of junior faculty who have the potential to integrate their expertise with biomedicine and to develop into productive investigators. |
| Duration: 3 to 5 years. |
| Provisions: Support is provided for salary up to $75,000 for a minimum 75% effort, fringe benefits, and other research expenses up to $25,000. |
| Applications Due: Standard dates |
|
See active K25 funding opportunities
|
|
|
|
| NIH Pathway to Independence (PI) Award |
| The Pathway to Independence Award is uniquely designed to facilitate the transition of outstanding postdoctoral candidates from mentored to independent research positions. The award contains two components, a mentored (K99) phase that can last up to 2 years and an independent (R00) phase, which will have a duration of 3 years. The objective of the program is to facilitate research independence earlier in an investigator's career. Investigators complete supervised research, and apply for an independent research faculty position, during the mentored phase of the award. Activation of the independent award phase is administrative, and is contingent upon the investigator securing an independent research position. Eligible candidates will have no more than 5 years of postdoctoral research at the time of application (initial or amended). Award recipients are expected to obtain R01 support during the independent phase of the award. |
| Provisions: For mentored candidates in an extramural institution, NIAMS will provide up to $50,000 per year for salary support (up to $75,000 per year for applicants with an M.D. degree), plus fringe, and up to $20,000 for research support costs. Budget details for mentored candidates in the NIH intramural program will be negotiated with the sponsoring laboratory and will be consistent with offers to scientists in comparable positions. |
|
See active K99/R00 funding opportunities
|
|
|
|
| Research Core Centers |
| To promote a cooperative interaction among basic science and clinical investigators in a manner that will enrich the effectiveness of ongoing research and promote new research. Any institution or consortium with an active program of excellence in basic and clinical biomedical research in skin diseases, musculoskeletal disorders or rheumatic diseases, may qualify for support through a Core Center. A strong biomedical research base is the prerequisite for establishment of a Core Center and an important component in considering continued funding of an established center. The components of a core center include 2 or more research cores, pilot and feasibility studies, and an administrative unit. |
| Duration: 5 years |
| Budget Cap: $400,000 direct costs |
| Applications Due: By RFA only |
| Additional Information: P30 Guidelines - PDF format WORD format |
|
|
|
| Centers of Research Translation (CORT) |
Contact: Ms. Justine Buschman
To promote translational research through a multidisciplinary approach on a disease specific theme. A CORT should have both basic and clinical research components. |
| Duration: 5 years |
| Budget Cap: $1,000,000 direct costs |
| Applications Due: By RFA only |
| Additional Information: CORT Guidelines - PDF format
WORD format |
|
|
|
| Specialized Centers of Research on Sex and Gender Factors Affecting Women’s Health (SCOR) |
Contact: Ms. Justine Bushman
The Office of Research on Women's Health (ORWH) serves as a focal point for women's health research at the NIH. The ORWH promotes, stimulates, and supports efforts to improve the health of women through biomedical and behavioral research. ORWH works in partnership with the NIH Institutes as well as the Food and Drug Administration (FDA) to ensure that women's health research is part of the scientific framework at NIH and throughout the scientific community.
The ORWH announces the Specialized Centers of Interdisciplinary Research on Sex and Gender Factors Affecting Women's Health (SCOR) program. These centers will provide new opportunities for interdisciplinary approaches to advancing studies on how sex and gender factors affect women's health. Each SCOR should develop an interdisciplinary research agenda bridging basic and clinical research on sex/gender factors underlying a priority women’s health issue. |
| Duration: 5 years |
| Budget Cap: $750,000 direct costs |
| Applications Due: By RFA only |
| Additional Information: ORWH SCOR Guidelines - PDF format
WORD format |
| Currently funded ORWH SCORs |
|
|
|
Specialized Centers of Research (SCOR)
(The NIAMS SCOR Program is being phased out.) |
| To promote a multidisciplinary attack on a specific disease, with both basic and clinical research as a requirement. The Institute currently supports SCORs in five disease areas: rheumatoid arthritis, osteoarthritis, osteoporosis, scleroderma, and systemic lupus erythematosus. SCORs differ from Research Program Project Grants in that they are developed in response to a request for applications from the Institute and must include clinical research as well as basic research. |
| Duration: 5 years |
| Budget Cap: $750,000 direct costs |
| Applications Due: By RFA only |
|
|
|
| Multidisciplinary Clinical Research Centers (MCRC) |
Contact: Ms. Justine Buschman
To support a full range of outstanding multidisciplinary clinical research on arthritis, musculoskeletal and skin diseases. Each MCRC is organized around a methodology core and includes a minimum of three highly meritorious projects encompassing clinical research drawing from two or more clinical approaches. The methodology core is the foundation of the Center, providing key support for development and implementation of clinical projects. The director of the MCRC, aided by an executive committee and the methodology core, provides leadership to focus all research projects on clinically relevant issues to prevent disease or to assess and/or to improve patient outcomes and to assure a rigorous research approach. Each project must address a critical issue that directly involves disease prevention or assessment and/or outcomes of patients whose diseases or disorders are within the mission of the NIAMS. |
| Duration: 5 years |
| Budget Cap: $800,000 direct costs |
| Applications Due: By RFA only |
| Additional Information: MCRC Guidelines - PDF format WORD format |
|
|
|
| Small Research Grants |
| The NIAMS Small Grant Program for New Investigators (R03) is intended for researchers that need funding to develop preliminary data for their first R01 application. These grants support studies related to arthritis, musculoskeletal or skin diseases or disorders. |
| Duration: No more than 3 years, not renewable. |
| Budget Cap: $50,000/yr. direct costs. |
| Applications Due: June 23, 2009; October 23, 2009; June 23, 2010; October 22, 2010; June 23, 2011 and October 24, 2011 |
| NIAMS also participates in other R03 program announcements for specific topics of research. |
|
See active R03 funding opportunities
|
|
|
|
| AREA Grants |
| Definition and other information provided under the R15 Guidelines related links. |
|
|
|
| NIAMS High Innovation Exploratory/Developmental Research Grant Program |
NIAMS accepts applications in response to PA-09-164 "NIH Exploratory/Developmental Research Grant Program (Parent R21)" proposing studies related to arthritis, musculoskeletal or skin diseases or disorders.
Potential applicants are strongly encouraged to discuss the suitability of the project for this program announcement with the NIAMS Program Director for that research topic area.
See NOT-AR-10-023 for additional information regarding NIAMS support for innovative research using R21 grants.
In making funding decisions on R21 applications, NIAMS will place a higher priority on projects that are:
- Innovative, ground-breaking projects with potential for significant impact;
- Projects that involve novel technology or tool development, and have the potential to significantly accelerate research fields;
- Projects that propose the novel application of methods, technologies, or conceptual approaches from outside biomedical science to a research problem in the NIAMS mission area.
Projects that will be considered a lower priority include:
- Projects specifically to develop preliminary data for longer-term projects in a well established research area;
- New investigator starter grants;
- Pilot projects that do not exhibit a high degree of innovation.
|
| Contact: See NIAMS supported scientific areas and contact information for the Program Directors. |
| Duration: 2 years |
| Budget Cap: $275,000 direct costs spread over two years |
| Applications Due: Standard dates |
Projects of limited time and scope that do not meet these characteristics of innovative, ground-breaking research should consider applying for a small Research Project Grant (Parent R01). For example, an R01 for two or three years at $100,000 direct cost per year could support a pilot project.
New investigators are encouraged to apply for an R01 (see NOT-OD-09-013, "Revised New and Early Stage Investigator Policies) or an R03 (see NIAMS Small Grant Program for New Investigators).
Preference in funding decisions for R21 grants will be given to projects within the NIAMS mission areas that are especially innovative, ground-breaking and have a high potential impact on these fields.
NIAMS also has funding opportunities for R21 grants on specific topics. The goal of supporting innovative, ground-breaking, highly significant research with the R21 activity code also applies to these funding opportunities.
|
|
See active R21 funding opportunities
|
|
|
|
| Education Projects |
| For support to develop and/or implement a program as it relates to a category in one or more of the areas of education, information, training, technical assistance, coordination, or evaluation. In this case, the Clinical Research Education and Career Development (CRECD) grant awards support development and implementation of curriculum-dependent programs in minority institutions to train selected doctoral and postdoctoral candidates in clinical research leading to a Master of Science in Clinical Research or Master of Public Health in a clinically relevant area. A successful program will result in an accredited master's degree program to produce trained and independent clinical researchers who can become engaged in conducting translational and/or patient-oriented research projects. |
| Duration: Up to 5 years to a minority institution |
| Budget Cap: $500,000/yr direct costs |
| Applications Due: By RFA only |
|
|
|
| Small Business Technology Transfer (STTR) Program |
The STTR program is a set aside program designed to support innovative research that has the potential for commercialization of the subject research conducted cooperatively by a small business concern and research institution. Innovation and the potential for commercialization are two of the review criteria considered in the scientific and technical merit evaluation process. At least 40 percent of the research project is to be conducted by the small business concern and at least 30 percent of the work is to be conducted by the single, “partnering” research institution.
Phase I (R41) is normally provided for one year/$100,000, which includes direct cost, facilities and administrative cost, and fixed fee. The facilities and administrative cost maximum is 40%, if no current negotiated rate. Fixed Fee is 7% maximum of direct cost and facilities and administrative cost for grantee institution only.
Phase II (R42) is normally two years/$750,000, which includes direct cost, facilities and administrative cost, and fixed fee. The facilities and administrative cost maximum is 25% or current negotiated rate. The applicant may negotiate with NIH. Fixed Fee is 7% maximum of direct cost and facilities and administrative cost for grantee institution only.
However, applicants may propose longer periods of time and greater amounts of funds necessary for completion of the project, prior discussion and justification with Program Official is required. |
| Applications Due: April 5, August 5, December 5 |
| Additional Information: Office of Extramural Research: Small Business Innovation Research (SBIR) and Small Business Technology (STTR) Programs |
|
See active R41/R42 funding opportunities
|
|
|
|
| Small Business Innovation Research (SBIR) Program |
To support small businesses in any biomedical or behavioral research area as described in the yearly solicitation.
Phase I (R43) is normally provided for six months/$100,000, which includes direct cost, facilities and administrative cost and fixed fee. The facilities and administrative cost maximum is 40%, if no current negotiated rate. Fixed Fee is 7% maximum of direct cost and facilities and administrative cost for grantee institution only.
Phase II (R44) is normally two years/$750,000, which includes direct cost, facilities and administrative cost and fixed fee. The facilities and administrative cost maximum is 25% or current negotiated rate. The applicant may negotiate with NIH. Fixed Fee is 7% maximum of direct cost and facilities and administrative cost for grantee institution only.
However, applicants may propose longer periods of time and greater amounts of funds necessary for completion of the project. |
| Applications Due: April 5, August 5, December 5 |
| Additional Information: Office of Extramural Research: Small Business Innovation Research (SBIR) and Small Business Technology (STTR) Programs |
|
See active R43/R44 funding opportunities
|
|
|
|
| Recovery Act Limited Competition: NIH Challenge Grants in Health and Science Research |
| This new program will support research on Challenge Topics which address specific scientific and health research challenges in biomedical and behavioral research that will benefit from significant 2-year jumpstart funds. Challenge Areas, defined by the NIH, focus on specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that would benefit from an influx of funds to quickly advance the area in significant ways. The research in these areas should have a high impact in biomedical or behavioral science and/or public health.
|
| Contact: Dr. Robert Carter |
| Duration: 2 years |
| Additional Information: http://grants.nih.gov/recovery/ |
| The American Recovery and Reinvestment Act of 2009 (Recovery Act) (H.R. 1, S. 1 - PDF-1MB) is a Federal public law passed by the 111th United States Congress and signed into law by President Barack Obama on February 17, 2009. The Recovery Act makes supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for the fiscal year ending September 30, 2009, and for other purposes.
RFA-OD-09-003
|
|
|
|
| Recovery Act Limited Competition: Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program |
| Contact: Mr. Elijah Weisberg |
| Additional Information: http://grants.nih.gov/recovery/ |
| RFA-OD-09-008 |
|
|
|
| Recovery Act Limited Competition: Building Sustainable Community-Linked Infrastructure to Enable Health Science Research |
| The ARRA also provides funding to the National Center for Research Resources (NCRR) to support extramural construction, repairs, and alterations in support of all NIH funded research institutions. ARRA also provides funding for shared instrumentation and other capital equipment to support all NIH activities.
|
| Contact: Ms. Shahnaz Khan |
| Applications Due: 12/11/2009 |
| Additional Information: http://grants.nih.gov/recovery/ |
| RFA-OD-09-010 |
|
See active RC4 funding opportunities
|
|
|
|
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants |
| NIAMS offers these grants to enable institutions to make NRSAs for predoctoral and postdoctoral research training to individuals selected by them in the fields of arthritis, muscle, bone, musculoskeletal, and/or skin diseases. |
| Duration: 5-year institutional grant (renewable). |
| Applications Due: May 25 |
|
See active T32 funding opportunities
|
|
|
|
| Research Project Cooperative Agreements |
| These are agreements between NIH and the award recipient in which the NIH acts as the partner in the research effort for projects similar to grants. |
|
See active U01 funding opportunities
|
|
|
|
| Specialized Center Cooperative Agreements |
| These agreements support research and development from basic to clinical, including ancillary supportive activities that create a multidisciplinary focus on a disease or biomedical problem. The centers may also serve as regional or national resources for special research purposes. |
|
See active U54 funding opportunities
|
|
|
|
| Cooperative Agreements |
| In these agreements, the award recipient retains the primary responsibility and dominant role for planning, directing, and executing the proposed project, with NIH staff being substantially involved as a partner with the awardee. |
|
Note: Supplemental applications accepted year round except from August 1 through October 1
|
Top |
|
|
| Supplements to Promote Diversity in Health-Related Research |
| Diversity supplements provide support for students, postdoctorates, and eligible investigators from groups that are underrepresented. Candidates may include individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. |
| Contact: Justine Buschman, M.S. |
| Additional Information: Research Supplements to Promote Diversity in Health-Related Research |
|
